Publications of J. Goergens

Ratz, L.; Brambillasca, C.; Bartke, L.; Huetzen, M. A.; Goergens, J.; Leidecker, O.; Jachimowicz, R. D.; van de Ven, M.; Proost, N.; Siteur, B. et al.; de Korte-Grimmerink, R.; Bouwman, P.; Pulver, E. M.; de Bruijn, R.; Isensee, J.; Hucho, T.; Pandey, G.; van Lohuizen, M.; Mallmann, P.; Reinhardt, H. C.; Jonkers, J.; Puppe, J.: Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Breast Cancer Res 24 (1), p. 41 (2022)

Schmidt, J.; Goergens, J.; Pochechueva, T.; Kotter, A.; Schwenzer, N.; Sitte, M.; Werner, G.; Altmüller, J.; Thiele, H.; Nürnberg, P. et al.; Isensee, J.; Li, Y.; Müller, C.; Leube, B.; Reinhardt, H. C.; Hucho, T.; Salinas, G.; Helm, M.; Jachimowicz, R. D.; Wieczorek, D.; Kohl, T.; Lehnart, S. E.; Yigit, G.; Wollnik, B.: Biallelic variants in YRDC cause a developmental disorder with progeroid features. Human Genetics 12 (140), pp. 1679 - 1693 (2021)

Jachimowicz, R. D.; Goergens, J.; Reinhardt, H. C.: DNA double-strand break repair pathway choice - from basic biology to clinical exploitation. Cell Cycle 18 (13), pp. 1423 - 1434 (2019)